> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FTC Finalizes Abbott/Alere Acquisition Consent Order
- URL: https://www.fdaweb.com/ftc-finalizes-abbott-alere-acquisition-consent-order/
- Published: 2017-11-15T12:00:00.000Z
- Updated: 2026-09-14T23:02:01.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5140134

The Federal Trade Commission (FTC) has [finalized](https://www.ftc.gov/news-events/press-releases/2017/11/ftc-approves-final-order-preserving-competition-us-markets-two?ref=fdaweb.com) a consent order it says is designed to remedy the anticompetitive effects resulting from Abbott’s $8.3 billion acquisition of Alere. Under the order, the parties will divest two of Alere’s point-of-care medical device product lines — point-of-care blood gas and point-of-care cardiac marker testing systems. In its September complaint, FTC alleged that the proposed acquisition would likely harm competition in the U.S. for those two types of medical devices.